Loading…
Cellyan Biotechnology Co., Ltd is projected to decline to $0.3576 by 2027, a -13% move from its current price of $0.4096. HKPD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.3844 | $0.4092 | $0.4357 | -0.09% |
| Aug 6 | $0.3742 | $0.4088 | $0.4467 | -0.19% |
| Aug 7 | $0.3665 | $0.4085 | $0.4553 | -0.28% |
| Aug 8 | $0.36 | $0.4081 | $0.4625 | -0.37% |
| Aug 9 | $0.3544 | $0.4077 | $0.469 | -0.47% |
| Aug 10 | $0.3494 | $0.4073 | $0.4748 | -0.56% |
| Aug 11 | $0.3448 | $0.4069 | $0.4803 | -0.65% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.3448 | $0.4069 | $0.4803 | -0.65% |
| Week 2 | $0.3198 | $0.4043 | $0.511 | -1.30% |
| Week 3 | $0.3014 | $0.4017 | $0.5352 | -1.94% |
| Week 4 | $0.2865 | $0.399 | $0.5558 | -2.58% |
| Week 5 | $0.2737 | $0.3964 | $0.5742 | -3.21% |
| Week 6 | $0.2625 | $0.3939 | $0.591 | -3.84% |
| Week 7 | $0.2524 | $0.3913 | $0.6066 | -4.47% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cellyan Biotechnology Co., Ltd is an investment holding company that engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services.
The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors.
The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.
HKPD (Cellyan Biotechnology Co., Ltd) is currently priced at $0.4425 with a market capitalization of $10.4M and a rank of 5075. The near-term picture shows a 2026 average price of $0.4425 with a neutral sentiment and a 0% ROI, accompanied by a 30-day price range of $0.2928 to $0.6687. This suggests limited upside versus the forecasted 2026 average.
Looking further ahead, the forecast envisions higher prices in the longer term. For example, 2032 shows an average of $0.5602 (ROI 26.6%), 2033 an average of $0.541 (ROI 22.3%), 2040 an average of $0.726 (ROI 64.1%), and 2050 an average of $1.02 (ROI 130.3%), with a generally bullish outlook in the later years.
A major floor 31.7% below — a decisive break under it would weaken the trend.
The nearest floor, 19.2% below — buyers have tended to step in here.
The nearest ceiling, 13.3% above — a clean break opens room to run.
A major ceiling 78.2% above — clearing it would confirm fresh momentum.
Key HKPD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HKPD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.4088 | Buy | $0.4099 | Sell |
| MA 10 | $0.3828 | Buy | $0.4011 | Buy |
| MA 20 | $0.4102 | Sell | $0.4046 | Buy |
| MA 50 | $0.4363 | Sell | $0.4465 | Sell |
| MA 100 | $0.5309 | Sell | $0.5339 | Sell |
| MA 200 | $0.7214 | Sell | $0.73 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.52 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 63.60 | Neutral |
| Williams %R (14) | -10.40 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -2.42 | Sell |
| Bollinger %B (20,2) | 0.71 | Neutral |
| Stochastic %K (14) | 89.60 | Sell |
| TRIX (15) | -0.54 | Sell |
| Awesome (5,34) | 0.00 | Buy |
| Ultimate (7,14,28) | 63.83 | Neutral |
| Momentum (10) | 0.06 | Buy |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 0.42 | Sell |
| ADX (14) | 11.91 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day technical picture for HKPD shows bullish sentiment with RSI14 at 50. The 50-day simple moving average is $0.4363 and the 200-day simple moving average is $0.7214. The price is positioned above the support level of $0.331 and below the resistance at $0.464.
The 30-day price range runs from a low of $0.2928 to a high of $0.6687, reflecting noticeable near-term volatility. Annualized volatility is listed at 100%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.331 | $0.4096 | $0.5052 | 0% | Neutral | |
| $0.2605 | $0.3576 | $0.5303 | -13% | Neutral | |
| $0.2439 | $0.356 | $0.5634 | -13% | Neutral | |
| $0.2045 | $0.3146 | $0.523 | -23% | Bearish | |
| $0.2092 | $0.3374 | $0.5842 | -18% | Bearish | |
| $0.2571 | $0.4334 | $0.777 | +6% | Neutral | |
| $0.2956 | $0.5199 | $0.9612 | +27% | Bullish | |
| $0.2739 | $0.5016 | $0.9534 | +22% | Bullish | |
| $0.2228 | $0.4246 | $0.8275 | +4% | Neutral | |
| $0.2203 | $0.4364 | $0.8705 | +7% | Neutral | |
| $0.3024 | $0.6719 | $1.47 | +64% | Bullish | |
| $0.4257 | $0.9461 | $2.18 | +131% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.331 | $0.4096 | $0.5186 | +0.00% |
| September 2026 | $0.3259 | $0.3961 | $0.5023 | -3.30% |
| October 2026 | $0.3052 | $0.3762 | $0.4868 | -5.02% |
| November 2026 | $0.3092 | $0.3854 | $0.5069 | +2.45% |
| December 2026 | $0.3006 | $0.3786 | $0.5052 | -1.76% |
Click any year to see its month-by-month HKPD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Cellyan Biotechnology Co., Ltd's 2026 outlook centres on $0.4096, within a $0.331 to $0.5052 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, HKPD could reach as high as $0.5303, with a base case around $0.3576 and support toward $0.2605 — roughly -13% from $0.4096. A consolidation phase looks the most probable path here.
Expect HKPD to range from $0.2439 to $0.5634 through 2028. The $0.356 average target implies a -13% move from current prices. That is 0% versus the projected 2027 average. Price action looks broadly range-bound.
The HKPD price prediction for 2029 points to an average of $0.3146 (low $0.2045, high $0.523) — a potential decline of -23% on today's $0.4096. Expect choppier, lower action through this leg of the cycle.
In 2030, HKPD is projected to trade between $0.2092 and $0.5842, averaging $0.3374 — a potential decline of -18% from today's $0.4096. That is up +7% on the projected 2029 average. A cyclical pullback looks likely — prices rarely move in a straight line.
Cellyan Biotechnology Co., Ltd's 2031 outlook centres on $0.4334, within a $0.2571 to $0.777 range. That is up +28% on the projected 2030 average. That marks a +6% change versus current levels. A consolidation phase looks the most probable path here.
By 2032, HKPD could reach as high as $0.9612, with a base case around $0.5199 and support toward $0.2956 — roughly +27% from $0.4096. Momentum favours further upside here.
Expect HKPD to range from $0.2739 to $0.9534 through 2033. The $0.5016 average target implies a +22% move from current prices. That is -4% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
The HKPD price prediction for 2034 points to an average of $0.4246 (low $0.2228, high $0.8275) — a potential gain of +4% on today's $0.4096. Price action looks broadly range-bound.
In 2035, HKPD is projected to trade between $0.2203 and $0.8705, averaging $0.4364 — a potential gain of +7% from today's $0.4096. That is up +3% on the projected 2034 average. A consolidation phase looks the most probable path here.
Cellyan Biotechnology Co., Ltd's 2040 outlook centres on $0.6719, within a $0.3024 to $1.47 range. That is up +54% on the projected 2035 average. That marks a +64% change versus current levels. Momentum favours further upside here.
By 2050, HKPD could reach as high as $2.18, with a base case around $0.9461 and support toward $0.4257 — roughly +131% from $0.4096. Buyers look set to stay in control over this stretch.
Investing $1,000 in HKPD today (≈ 2,441.40625 HKPD) could be worth
$2,309.77
+$1,309.77 (+131%) by 2050 · US Dollar
Based on the average projected HKPD price of $0.95 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HKPDwould be worth at today's price.
$1,000 invested in HKPD on Jul 31, 2025 (≈ 925.069406 HKPD) would be worth
$378.91
-$621.09 (-62.1%) today · 0.38× · US Dollar
Based on a HKPD entry price of $1.08 vs. today's $0.4096.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.365 | $1,122.19 | +12.2% |
| 1 month ago | $0.405 | $1,011.36 | +1.1% |
| 3 months ago | $0.685 | $597.96 | -40.2% |
| 6 months ago | $0.77 | $531.95 | -46.8% |
| 1 year ago | $1.08 | $378.91 | -62.1% |
| All time (1.5y) ago | $2.82 | $145.25 | -85.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HKPD forecast.
Our base-case forecast reaches $0.82 around 2050.
Implied market cap at $0.82: $13.41M
The multi-year forecast presents a mixed to improving trajectory through the 2020s and into the 2040s and 2050s. In 2030 the average price is projected to be $0.3642 with a -17.7% ROI and Bearish sentiment, indicating a potential near-term weakness.
The model then turns more constructive in the early 2030s, with 2032 at an average of $0.5602 (ROI 26.6%, Bullish) and 2033 at $0.541 (ROI 22.3%, Bullish). This suggests a shift toward higher price levels and an improving outlook over that span.
Longer term, 2040 is forecast at an average of $0.726 (ROI 64.1%, Bullish) and 2050 at an average of $1.02 (ROI 130.3%, Bullish), pointing to substantial potential upside if the trends hold. These figures illustrate a path from early-year weakness to meaningful gains by the end of the decade and into mid-century, while noting that outcomes are not guaranteed and depend on future conditions.
Tap a question to reveal the answer.
2030: average price $0.3642, min $0.2258, max $0.6307, ROI -17.7%, sentiment Bearish.
Forecasts show mixed signals: 2026 average $0.4425 (ROI 0%, Neutral), 2030 ROI -17.7% (Bearish), then stronger upside later with 2040 ROI 64.1% (Bullish) and 2050 ROI 130.3% (Bullish). This indicates higher risk with potential gains in the longer term.
The 2050 maximum is $2.34 with an average of $1.02 and ROI 130.3% (Bullish). While the high end reaches $2.34 in the forecast, it remains not guaranteed and depends on future conditions.
Current price is $0.4425 and market cap is $10.4M.
Bullish sentiment with RSI14 at 50; SMA50 is $0.4363 and SMA200 is $0.7214. There is support at $0.331 and resistance at $0.464. The 30-day range is $0.2928 to $0.6687, with annualized volatility of 100%.
Cellyan Biotechnology Co., Ltd Community Discussion
0Share your Cellyan Biotechnology Co., Ltd price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.